S134: FLAG-IDA COMBINED WITH GEMTUZUMAB OZOGAMICIN (GO) REDUCED MRD LEVELS AND IMPROVED OVERALL SURVIVAL IN NPM1MUT AML INDEPENDENT OF FLT3 AND MRD STATUS, RESULTS FROM THE AML19 TRIAL

Detalles Bibliográficos
Autores principales: Russell, Nigel, Othman, Jad, Dillon, Richard, Potter, Nicola, Wilhelm-Benartzi, Charlotte, Knapper, Steven, Batten, Leona, Canham, Joanna, Hinson, Emily Laura, Malthe Overgaard, Ulrik, Gilkes, Amanda, Mehta, Priyanka, Kottaridis, Panagiotis, Cavenagh, Jamie, Hemmaway, Claire, Arnold, Claire, Freeman, Sylvie, Dennis, Mike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Oral Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428495/
http://dx.doi.org/10.1097/01.HS9.0000967448.25247.8c
Descripción
Sumario:

Ejemplares similares